Bone Biologics Corporation
Hedge Funds Holdings
Last updated:
Bone Biologics Corporation‘s stocks are currently a part of 3 hedge funds’ portfolios, which represents 1.18% of the total amount of its stocks outstanding. This makes up a total of 52.01K shares of Bone Biologics Corporation. Compared to the previous quarter, the number fell by -97.70% or -2.21M shares fewer. As for the holding position changes, 66.67% (2) of current hedge fund investors increased the number of shares held, and 66.67% (2) closed the holdings completely.
Hedge funds holding Bone Biologics (Q1 2022 – Q1 2023)
| Q1 2022 | 3 |
|---|---|
| Q2 2022 | 3 |
| Q3 2022 | 2 |
| Q4 2022 | 12 |
| Q1 2023 | 3 |
Hedge funds changes in Bone Biologics positions (Q1 2022 – Q1 2023)
| Q1 2022 | 3 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q2 2022 | 2 | 0 | 0 | 2 | -1 |
| Q3 2022 | 0 | 1 | 0 | 1 | 0 |
| Q4 2022 | 11 | 1 | 0 | 1 | -1 |
| Q1 2023 | 0 | 2 | 0 | 2 | -1 |
Top 50 hedge fund holders of Bone Biologics Corporation (NASDAQ:BBLG)
| Hedge fund | Value | Shares owned | Portfolio share |
|---|---|---|---|
| VANGUARD GROUP INC | 35K | 33.46K | 0.000% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 8K | 7.87K | 0.000% |
| UBS GROUP AG | 0 | 0 | 0.000% |